Bioactive natural products from fungicolous Hawaiian isolates: secondary metabolites from a Phialemoniopsis sp.

Mycology

Volumn 5, Issue 3, 2014, Pages 120-129

  Kaur, Amninder ^a   Rogers, Kristina D ^a   Swenson, Dale E ^a   Dowd, Patrick F ^b   Wicklow, Donald T ^b   Gloer, James B ^a  

^a University of Iowa   (United States)

^b NATIONAL CENTER FOR AGRICULTURAL UTILIZATION RESEARCH   (United States)

Author keywords

destruxin; gabusectin; oxirapentyn; Phialemoniopsis curvata; Phialemonium

Indexed keywords

FUNGI; PHIALEMONIUM; PHIALEMONIUM CURVATUM;

EID: 84904749834     PISSN: 21501203     EISSN: 21501211     Source Type: Journal    
DOI: 10.1080/21501203.2014.931309     Document Type: Article

References (23)

1. Dowd PF, Johnson ET, Pinkerton TS. 2007. Oral toxicity of β-N-acetyl hexosaminidase to insects. J Agric Food Chem. 55:3421-3428. doi:10.1021/jf063562w
2. Gams W, Mcginnis MR. 1983. Phialemonium, a new Anamorph genus intermediate between Phialophora and Acremonium. Mycologia. 75:977-987. doi:10.2307/3792653
3. Gloer JB. 2007. Applications of fungal ecology in the search for new bioactive natural products. In: Kubicek CP, Druzhinina IS, editors. Environmental and microbial relationships. 2nd ed. The Mycota IV. Berlin Heidelberg: Springer-Verlag; p. 257-283.
4. Guarro J, Nucci M, Akiti T, Gene J, Cano J, Barreiro MDC, Aguilar C. 1999. Phialemonium fungemia: two documented nosocomial cases. J Clin Microbiol. 37:2493-2497.
5. Hellwig V, Grothe T, Mayer-Bartschmid A, Endermann R, Geschke FU, Henkel T, Stadler M. 2002. Altersetin, a new antibiotic from cultures of endophytic Alternaria spp. taxonomy, fermentation, isolation, structure elucidation and biological activities. J Antibiot. 55:881-892. doi:10.7164/antibiotics.55.881
6. Hiratsuka Y, Chakravarty P. 1999. Role of Phialemonium curvatum as a potential biological control agent against a blue stain fungus on aspen. Forest Pathol. 29:305-310. doi:10.1046/j.1439-0329.1999.00160.x
7. Höller U, Gloer JB, Wicklow DT. 2002. Biologically active polyketide metabolites from an undetermined fungicolous hyphomycete resembling Cladosporium. J Nat Prod. 65:876-882. doi:10.1021/np020097y
8. Krasnoff SB, Gibson DM, Belofsky GN, Gloer KB, Gloer JB. 1996. New destruxins from the entomopathogenic fungus Aschersonia sp. J Nat Prod. 59:485-489. doi:10.1021/np9601216
9. Ley SV, Smith SC, Woodward PR. 1992. Further reactions of tert-butyl 3-oxobutanthioate and tert-butyl 4-diethyl-phosphono-3-oxobutanthioate - carbonyl coupling reactions, amination, use in the preparation of 3-acyltetramic acids and application to the total synthesis of fuligorubin-A. Tetrahedron. 48:1145-1174. doi:10.1016/S0040-4020(01)88210-7
10. Lira SP, Vita-Marques AM, Seleghim MHR, Bugni TS, Labarbera DV, Sette LD, Sponchiado SRP, Ireland CM, Berlinck RGS. 2006. New destruxins from the marine-derived fungus Beauveria felina. J Antibiot (Tokyo). 59:553-563. doi:10.1038/ja.2006.76
11. Marfori EC, Kajiyama S, Fukusaki E, Kobayashi A. 2002. Trichosetin, a novel tetramic acid antibiotic produced in dual culture of Trichoderma harzianum and Catharanthus roseus callus. Z Naturforsch C. 57:465-470.
12. Neff SA, Lee SU, Asami Y, Ahn JS, Oh H, Baltrusaitis J, Gloer JB, Wicklow DT. 2012. Aflaquinolones A-G: secondary metabolites from marine and fungicolous isolates of Aspergillus spp. J Nat Prod. 75:464-472. doi:10.1021/np200958r
13. Pedras MSC, Zaharia LI, Ward DE. 2002. The destruxins: synthesis, biosynthesis, biotransformation, and biological activity. Phytochemistry. 59:579-596. doi:10.1016/S0031-9422(02)00016-X
14. Perdomo H, Garcia D, Gene J, Cano J, Sutton DA, Summerbell R, Guarro J. 2013. Phialemoniopsis, a new genus of sordariomycetes, and new species of Phialemonium and Lecythophora. Mycologia. 105:398-421. doi:10.3852/12-137
15. Perdomo H, Sutton DA, Garcia D, Fothergill AW, Gene J, Cano J, Summerbell RC, Rinaldi MG, Guarro J. 2011. Molecular and phenotypic characterization of Phialemonium and Lecythophora isolates from clinical samples. J Clin Microbiol. 49:1209-1216. doi:10.1128/JCM.01979-10
16. Proia LA, Hayden MK, Kammeyer PL, Ortiz J, Sutton DA, Clark T, Schroers HJ, Summerbell RC. 2004. Phialemonium: an emerging mold pathogen that caused 4 cases of hemodialysis-associated endovascular infection. Clin Infect Dis. 39:373-379. doi:10.1086/422320
17. Rivero M, Hidalgo A, Alastruey-Izquierdo A, Cía M, Torroba L, Rodríguez-Tudela JL. 2009. Infections due to Phialemonium species: case report and review. Med Mycol. 47:766-774. doi:10.3109/13693780902822800
18. Schiell M, Knauf M, Toti L, Markus-Erb A, Inventors, Assignee: Aventis Pharma Deutschland GmbH, Germany. 2003. Fermentative preparation of Gabusectin and its use as an antibacterial. German patent DE10156906A1.
19. Singh SB, Zink DL, Goetz MA, Dombrowski AW, Polishook JD, Hazuda DJ. 1998. Equisetin and a novel opposite stereochemical homolog phomasetin, two fungal metabolites as inhibitors of HIV-1 integrase. Tetrahedron Lett. 39:2243-2246. doi:10.1016/S0040-4039(98)00269-X
20. Takahashi S, Itoh Y, Takeuchi M, Furuya K, Kodama K, Naito A, Haneishi T, Sato S, Tamura C. 1983. Isolation and structure of oxirapentyn. J Antibiot (Tokyo). 36:1418-1420. doi:10.7164/antibiotics.36.1418
21. Vesonder RF, Tjarks LW, Rohwedder WK, Burmeister HR, Laugal JA. 1979. Equisetin, an antibiotic from Fusarium equiseti Nrrl-5537, identified as a derivative of N-methyl-2,4-pyrollidone. J Antibiot (Tokyo). 32:759-761. doi:10.7164/antibiotics.32.759
22. Wicklow DT, Joshi BK, Gamble WR, Gloer JB, Dowd PF. 1998. Antifungal metabolites (monorden, monocillin IV, and cerebrosides) from Humicola fuscoatra Traaen NRRL 22980, a mycoparasite of Aspergillus flavus sclerotia. Appl Environ Microbiol. 64:4482-4484.
23. Yurchenko AN, Smetanina OF, Khudyakova YV, Kirichuk NN, Chaikina EL, Anisimov MM, Afiyatullov SS. 2013. New oxirapentyn E from marine isolate of the fungus Isaria felina. Chem Nat Compd. 49:857-860. doi:10.1007/s10600-013-0764-0